全文获取类型
收费全文 | 3023篇 |
免费 | 157篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 146篇 |
妇产科学 | 21篇 |
基础医学 | 249篇 |
口腔科学 | 104篇 |
临床医学 | 248篇 |
内科学 | 586篇 |
皮肤病学 | 28篇 |
神经病学 | 396篇 |
特种医学 | 258篇 |
外科学 | 483篇 |
综合类 | 26篇 |
一般理论 | 1篇 |
预防医学 | 203篇 |
眼科学 | 51篇 |
药学 | 153篇 |
中国医学 | 2篇 |
肿瘤学 | 163篇 |
出版年
2022年 | 18篇 |
2021年 | 28篇 |
2020年 | 33篇 |
2019年 | 36篇 |
2018年 | 44篇 |
2017年 | 36篇 |
2016年 | 47篇 |
2015年 | 45篇 |
2014年 | 64篇 |
2013年 | 70篇 |
2012年 | 116篇 |
2011年 | 113篇 |
2010年 | 70篇 |
2009年 | 99篇 |
2008年 | 110篇 |
2007年 | 134篇 |
2006年 | 113篇 |
2005年 | 114篇 |
2004年 | 101篇 |
2003年 | 100篇 |
2002年 | 104篇 |
2001年 | 86篇 |
2000年 | 114篇 |
1999年 | 97篇 |
1998年 | 62篇 |
1997年 | 55篇 |
1996年 | 60篇 |
1995年 | 42篇 |
1994年 | 35篇 |
1993年 | 38篇 |
1992年 | 62篇 |
1991年 | 83篇 |
1990年 | 79篇 |
1989年 | 67篇 |
1988年 | 85篇 |
1987年 | 69篇 |
1986年 | 49篇 |
1985年 | 65篇 |
1984年 | 55篇 |
1983年 | 33篇 |
1982年 | 26篇 |
1981年 | 17篇 |
1980年 | 27篇 |
1979年 | 28篇 |
1978年 | 21篇 |
1977年 | 22篇 |
1976年 | 29篇 |
1975年 | 23篇 |
1974年 | 24篇 |
1969年 | 11篇 |
排序方式: 共有3188条查询结果,搜索用时 15 毫秒
31.
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. 总被引:1,自引:0,他引:1
Daniel L Hamilos Anthony D'Urzo Robin J Levy Michael Marcus Kenneth Tripp Merdad Parsey Rudolf A Baumgartner William K McVicar 《Annals of allergy, asthma & immunology》2007,99(6):540-548
BACKGROUND: Previous studies have raised concerns regarding the safety of regular use of beta2-agonists for treating asthma. Few studies have explored the safety of at least 1 year of use of racemic albuterol, and none have examined long-term dosing of levalbuterol. OBJECTIVE: To examine the long-term safety of levalbuterol hydrofluoroalkane (HFA) vs racemic albuterol HFA administered via metered-dose inhaler (MDI) in patients with stable asthma. METHODS: Patients with mild to moderate asthma (mean forced expiratory volume in 1 second [FEVI], 68.3% of predicted) 12 years or older participated in a multicenter, parallel-group, open-label study. Patients were randomized to levalbuterol HFA MDI (90 microg; 2 actuations of 45 microg; n = 496) or racemic albuterol HFA MDI (180 microg; 2 actuations of 90 microg; n = 250) for 52 weeks of 4 times daily dosing. The primary end point was the incidence of postrandomization adverse events. Asthma exacerbations and pulmonary parameters were also assessed. RESULTS: The overall incidence of adverse events was similar for levalbuterol (72.0%) and racemic albuterol (76.8%). Rates of beta-mediated adverse events, serious adverse events, and discontinuations because of adverse events were low (<15%) and were comparable between groups. Rates of asthma adverse events for levalbuterol and racemic albuterol were 18.3% and 19.6%, respectively. Mean percentage of predicted FEV1 improved after dosing and was stable for both groups. CONCLUSION: In this trial, up to 52 weeks of regular use of levalbuterol HFA MDI or racemic albuterol HFA MDI was well tolerated, and no deterioration of lung function was detected during the study period. 相似文献
32.
33.
34.
Moreau MF Thibaud JL Miled LB Chaussepied M Baumgartner M Davis WC Minoprio P Langsley G 《Infection and immunity》1999,67(12):6678-6682
Theileria parasites infect and transform bovine leukocytes. We have analyzed laboratory-established Theileria sp.-infected leukocyte lines and observed that transformed macrophages express CD5. Low-level expression of CD5 by macrophages was further confirmed on three independent Theileria annulata clinical isolates from Tunisia. Interestingly, the fourth CD5(+) clinical isolate (MB2) was morphologically different, expressed surface immunoglobulin M (IgM) and BoLA class II, and had rearranged Ig light-chain genes. To demonstrate that MB2 did indeed contain CD5(+) B cells, individual clonal lines were obtained by limiting dilution, and CD5 expression and Ig gene rearrangement were confirmed. This suggests that in natural infections T. annulata can invade and transform CD5(+) B cells. 相似文献
35.
Prof. Dr. R. Knüchel A. Hartmann R. Stöhr R. Baumgartner D. Zaak R. C. Krieg 《Der Pathologe》2003,24(6):473-480
Zusammenfassung In der Fluoreszenzdiagnostik [Lichtanregung nach Gabe des physiologischen Hämmetaboliten 5-Aminolävulinsäure (ALA)] erscheinen Präneoplasien und Neoplasien rot fluoreszierend, was wahrscheinlich auf eine tumorzellselektive Anreicherung des intrazellulär aus ALA gebildeten Metaboliten Protoporphyrin IX zurückzuführen ist. Die mit dieser Methode mögliche frühe Detektion von Tumoren und Präneoplasien erlaubt deren genetische Analyse und damit Vergleiche von Aussagen der Fluoreszenz-in-situ-Hybridisierung und Loss-of-heterozygosity-Analyse hinsichtlich Deletionsnachweis und Gensequenzierung. Neue Daten zu Deletionen und Chromosomenaberrationen sowie eine etwa 30%ige Oligoklonalität von Tumoren werden dargestellt. Die tumorselektive Fluoreszenz scheint biochemisch durch Unterschiede im Hämmetabolismus bedingt zu sein. Durch Gen- und Proteinexpressionsanalysen können evtl. weitere, mit dem Hämmetabolismus assoziierte, tumorspezifische Moleküle identifiziert werden.Die geschilderten Arbeiten erfolgten im Rahmen von Unterstützungen durch die Deutsche Krebshilfe 10-1096-Ha und 70.2200-Ba sowie Industriekooperationen von Medac GmbH und metaGen Pharmaceuticals. 相似文献
36.
Santer R Muhle H Suormala T Baumgartner ER Duran M Yang X Aoki Y Suzuki Y Stephani U 《Molecular genetics and metabolism》2003,79(3):160-166
We report the clinical course and biochemical findings of a 10-year-old, mentally retarded girl with late-onset holocarboxylase synthetase (HCS, gene symbol HLCS) deficiency and only partial response to biotin. On treatment, even with an unusually high dose of 200mg/day, activities of the biotin-dependent mitochondrial carboxylases in lymphocytes remained below 50% of the mean control values. Not only urinary 3-hydroxyisovaleric acid excretion has been persistently elevated, but also plasma and, with even higher concentrations, cerebrospinal fluid 3-hydroxyisovaleric acid have not normalized. The unusual and insufficient response of this patient to biotin treatment can be explained by the effect of the combination of the common HLCS allele IVS10 +5 g>a on one chromosome and a truncating mutation on the other. This case illustrates mechanisms involved in the genotype-phenotype correlation that unequivocally exists in HCS deficiency. 相似文献
37.
Dou Q; Tarnuzzer RW; Williams RS; Schultz GS; Chegini N 《Molecular human reproduction》1997,3(11):1005-1014
38.
39.
Fifty women with polycystic ovaries took part in a prospective randomized
study. All women required treatment by in-vitro fertilization (IVF) for
reasons other than anovulation. They had all previously undergone ovarian
stimulation with gonadotrophin therapy which had failed to result in
pregnancy or had been abandoned due to high risk of developing ovarian
hyperstimulation syndrome (OHSS). Twenty-five women were treated by
long-term pituitary desensitization followed by gonadotrophin therapy,
oocyte retrieval and embryo transfer (group 1). Twenty-five women underwent
laparoscopic ovarian electrocautery after pituitary desensitization
followed by gonadotrophin therapy, oocyte retrieval and embryo transfer
(group 2). A significantly higher number of women in group 1 had to have
the treatment cycle abandoned due to impending or actual OHSS, determined
by endocrine and clinical findings. In addition, the development of
moderate or severe OHSS in completed cycles was higher in group 1. The
pregnancy rate and miscarriage rates in the two treatment groups were
similar. The authors propose that laparoscopic ovarian electrocautery is a
potentially useful treatment for women who have previously had an IVF
treatment cycle cancelled due to risk of OHSS or who have suffered OHSS in
a previous treatment cycle.
相似文献
40.
Peduto A Baumgartner MR Verhoeven NM Rabier D Spada M Nassogne MC Poll-The BT Bonetti G Jakobs C Saudubray JM 《Molecular genetics and metabolism》2004,82(3):224-230
Peroxisomal disorders include a complex spectrum of diseases, characterized by a high heterogeneity from both the clinical and the biochemical points of view. Specific assays are required for the study of peroxisome metabolism. Among these, pipecolic acid evaluation is considered as a supplementary test. We have established the diagnostic role of pipecolic acid in 30 patients affected by a peroxisomal defect (5 Zellweger syndromes, 10 Infantile Refsum diseases, 1 neonatal adrenoleukodystrophy, 6 patients affected by a peroxisomal biogenesis disorder with unclassified phenotype, 1 case of rhizomelic chondrodysplasia punctata (RCDP), 2 acyl-CoA oxidase deficiencies, 2 bifunctional enzyme deficiencies, 2 Refsum diseases, and 1 beta-oxidation deficiency). Pipecolic acid was increased in all generalized peroxisomal disorders, while normal pipecolic acid with abnormal very long chain fatty acid concentrations was strong evidence for a single peroxisomal enzyme deficiency. Unexpectedly, hyperpipecolic acidaemia was found also in a child affected by RCDP and in two patients with Refsum disease. In six patients the suggestion of a peroxisomal disorder was raised by the fortuitous finding of a pipecolic acid peak in amino acid chromatography, routinely performed as a general metabolic screening. For all patients, pipecolic acid proved to be a useful parameter in the biochemical classification of peroxisomal disorders. 相似文献